Showing results (1031-1040 of 1,139) with videos related to

Sort By:
Pageof 114
Pain Medicine (Malden, Mass.)|April 8, 2020
Pain Management Best Practices from Multispecialty Organizations During the COVID-19 Pandemic and Public Health CrisesSteven P Cohen, Zafeer B Baber, Asokumar Buvanendran, et al.
Neuroimage. Clinical|March 31, 2019
Visual network alterations in brain functional connectivity in chronic low back pain: A resting state functional connectivity and machine learning studyWei Shen, Yiheng Tu, Randy L Gollub, et al.
Journal of Clinical and Experimental Hepatology|April 27, 2019
Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for CholangiocarcinomaChristopher A Wadsworth, Peter H Dixon, Simon Taylor-Robinson, et al.
Cureus|January 8, 2024
The Role of Clinical Pharmacists in Antimicrobial Stewardship Programs (ASPs): A Systematic ReviewIbrahim M Dighriri, Bayader A Alnomci, Mashael M Aljahdali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2026
A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3S Kopetz, J Tabernero, S Lonardi, et al.
Pain|September 2, 2025
Real-world data and evidence in pain research: an IMMPACT comprehensive review and best practice recommendationsJan Vollert, John Spivack, Blythe Adamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated <i>BRAF</i> V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON StudyJosep Tabernero, Axel Grothey, Eric Van Cutsem, et al.
Future Oncology (London, England)|July 18, 2020
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with <i>FGFR2</i> rearrangementsTanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2019
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With <i>BRAF</i> V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer StudyEric Van Cutsem, Sanne Huijberts, Axel Grothey, et al.
JOR Spine|August 21, 2025
Quantitative Sensory Testing in an Observational Cohort of Adults With Chronic Low Back PainMichael J Schneider, Carol M Greco, Amanda M Acevedo, et al.
Pageof 114